Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...
America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...
Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent ...
Sarah Todd returned to reporting in January 2025 after being assignment editor at STAT since October 2022. You can reach Sarah on Signal at sarahlizchar.47. The big takeaway from a new government ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical ...
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results